When the most significant differences in autoantibody levels at month 6 were considered (P < 10−4), only the antibodies against CCL19 were higher in previously hospitalized COVID-19 convalescents compared with healthy controls, while antibodies against 8 chemokines (CXCL8, CCL22, CXCL16, CCL27, CXCL7, CCL20, CX3CL1 and CCL19) were increased in outpatient COVID-19 convalescents compared with healthy controls (Fig. 1e and Extended Data Fig. 5a). This evidence concerns the gene CXCL8 and COVID-19.